XML 80 R48.htm IDEA: XBRL DOCUMENT v3.21.2
Restatement of Previously Issued Financial Statements - Impact of the Restatement on the Statement of Cash Flows (Details) - USD ($)
 3 Months Ended 5 Months Ended 6 Months Ended 8 Months Ended 11 Months Ended
Jun. 30, 2021
Sep. 30, 2020
Jun. 30, 2020
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Sep. 30, 2020
Dec. 31, 2020
Change in fair value of derivative warrant liabilities $ 18,834,160   $ 0 $ 0 $ (3,303,710) $ 0   $ 28,525,220
Change in fair value of derivative warrant liabilities               (28,525,230)
Financing costs allocated to derivative warrant liabilities               964,140
Net cash used in operating activities         $ (444,974) $ 0   (592,406)
Net cash used in investing activities               (414,000,000)
Net cash provided by financing activities               415,454,160
Previously Reported                
Net loss               (140,280)
Net loss             $ (90,697)  
Change in fair value of derivative warrant liabilities   $ 0         0 0
Change in fair value of derivative warrant liabilities             0  
Financing costs allocated to derivative warrant liabilities   0         0 0
Net cash used in operating activities             (501,937) (592,406)
Net cash used in investing activities             (414,000,000) (414,000,000)
Net cash provided by financing activities             415,454,160 415,454,160
Net change in cash             952,223 861,754
Revision of Prior Period, Adjustment                
Net loss               (29,489,360)
Net loss             (22,139,590)  
Change in fair value of derivative warrant liabilities   21,175,450         21,175,450 28,525,220
Change in fair value of derivative warrant liabilities             21,175,450  
Financing costs allocated to derivative warrant liabilities   964,140         964,140 964,140
Net cash used in operating activities             0 0
Net cash used in investing activities             0 0
Net cash provided by financing activities             0 0
Net change in cash             0 0
As Restated                
Net loss               (29,629,640)
Net loss             (22,230,287)  
Change in fair value of derivative warrant liabilities   21,175,460         21,175,450 28,525,220
Change in fair value of derivative warrant liabilities             21,175,450  
Financing costs allocated to derivative warrant liabilities   $ 964,140         964,140 964,140
Net cash used in operating activities             (501,937) (592,406)
Net cash used in investing activities             (414,000,000) (414,000,000)
Net cash provided by financing activities             415,454,160 415,454,160
Net change in cash             $ 952,223 $ 861,754